And the winner is...

[admin]

 

1.  XXII from Streamingeagle on July 4 from $0.92 to $2.14 +132.6%
2. DSNY by Admin on June 9: from $1.14 to $1.90 +66.6%
3. GIVN by Kaliboo on Nov 16 from $22.69 to $30.08 +32.5%
4. LRAD from Kaliboo on Nov 16 from $1.66 to $1.88 +13.2%
5. TASR from Kaliboo on Nov 16 from $17.49 to $15.88 -9.2%
6. LNCGY from Movieguy on July 21 from $16.19 to $12.12 -25.1%
7. UNXL from Paciottiman on July 28 from $13.75 to $10.01 -27.2% 

Well we have a clear winner in the form of XXII from Streamingeagle. Even if the competition wasn't entirely fair as there were some late entries that didn't have much time to perform. And this is only a rather arbitrary cut off date, tomorrow can be quite different..

 

[streamingeagle88]

[quote='admin' pid='35475' dateline='1388670304']

 

1.  XXII from Streamingeagle on July 4 from $0.92 to $2.14 +132.6%
2. DSNY by Admin on June 9: from $1.14 to $1.90 +66.6%
3. GIVN by Kaliboo on Nov 16 from $22.69 to $30.08 +32.5%
4. LRAD from Kaliboo on Nov 16 from $1.66 to $1.88 +13.2%
5. TASR from Kaliboo on Nov 16 from $17.49 to $15.88 -9.2%
6. LNCGY from Movieguy on July 21 from $16.19 to $12.12 -25.1%
7. UNXL from Paciottiman on July 28 from $13.75 to $10.01 -27.2% 

Well we have a clear winner in the form of XXII from Streamingeagle. Even if the competition wasn't entirely fair as there were some late entries that didn't have much time to perform. And this is only a rather arbitrary cut off date, tomorrow can be quite different..

 

And for XXII this is only the very beginning. Recovering IOC addicts have a look.

[admin]

Yes, I actually believe XXII will have a very good year as well. Their patent portfolio is really unmatched in the space, they're not likely to need new capital soon, and they will start their own manufacturing pretty soon. This in itself will put further upward pressure on the stock, but it's the regulatory process where the really big possibilities lie.